Drug shortages homepage
Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.
A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.
Below are the newest and most recently updated Shortage and Discontinuation reports.
Shortage Reports
| Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
|---|---|---|---|---|---|---|
| AURALGAN | PALADIN LABS INC | Actual shortage | 54MG 14MG | Updated Report | 2019-08-22 | 85734 |
| ACT ESOMEPRAZOLE | TEVA CANADA LIMITED | Anticipated shortage | 20MG | New Report | 2019-08-22 | 92241 |
| ACT ESOMEPRAZOLE | TEVA CANADA LIMITED | Anticipated shortage | 20MG | New Report | 2019-08-22 | 92238 |
| ACT CELECOXIB | ACTAVIS PHARMA COMPANY | Anticipated shortage | 100MG | New Report | 2019-08-22 | 92235 |
| ACT CELECOXIB | ACTAVIS PHARMA COMPANY | Anticipated shortage | 100MG | New Report | 2019-08-22 | 92232 |
| ACT LATANOPROST/TIMOLOL | ACTAVIS PHARMA COMPANY | Anticipated shortage | 5MG 50MCG | New Report | 2019-08-22 | 92229 |
| ACT METHYLPHENIDATE ER | ACTAVIS PHARMA COMPANY | Actual shortage | 54MG | Updated Report | 2019-08-22 | 65999 |
| ACT METHYLPHENIDATE ER | ACTAVIS PHARMA COMPANY | Actual shortage | 36MG | Updated Report | 2019-08-22 | 65996 |
| ACT METHYLPHENIDATE ER | ACTAVIS PHARMA COMPANY | Actual shortage | 27MG | Updated Report | 2019-08-22 | 65993 |
| ACT METHYLPHENIDATE ER | ACTAVIS PHARMA COMPANY | Actual shortage | 18MG | Updated Report | 2019-08-22 | 65990 |
Discontinuation Reports
| Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
|---|---|---|---|---|---|---|
| SODIUM IODIDE I 131 ORAL SOLUTION | MALLINCKRODT RP CANADA INC | Discontinued | 5mCi, 10mCi, 20mCi, 25mCi, 35mCi, 50mCi, 100mCi, 150mCi, 75mCi | New Report | 2019-08-21 | 92069 |
| SODIUM IODIDE I-131 CAPSULES | MALLINCKRODT RP CANADA INC | Discontinued | 0.75mCi, 2mCi, 3mCi, 4mCi, 5mCi, 6mCi, 7mCi, 8mCi, 10mCi, 12mCi, 15mCi, 17mCi, 20mCi, 50mmCi, 100mCi | New Report | 2019-08-21 | 92065 |
| VIRAMUNE XR | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | Discontinued | 400MG | New Report | 2019-08-21 | 92063 |
| DEPO-PROVERA STERILE AQUEOUS SUSPENSION 50 MG/ML | PFIZER CANADA ULC | Discontinued | 50MG | Updated Report | 2019-08-19 | 79400 |
| TEVA-LISINOPRIL (TYPE Z) | TEVA CANADA LIMITED | Discontinued | 10MG | New Report | 2019-08-15 | 91648 |
| DIANEAL PD4 CAPD SOLUTION WITH 1.5% DEXTROSE AND 2.5MEQ/L CALCIUM | BAXTER CORPORATION | To be discontinued | 448MG 1.5G 5.08MG 18.3MG 538MG | New Report | 2019-08-12 | 91388 |
| DIANEAL PD4 CAPD SOLUTION WITH 2.5% DEXTROSE AND 2.5MEQ/L CALCIUM | BAXTER CORPORATION | To be discontinued | 448MG 2.5G 5.08MG 18.3MG 538MG | New Report | 2019-08-12 | 91392 |
| DIANEAL PD 101 CAPD SOLUTION W 1.5% DEXTROSE | BAXTER CORPORATION | To be discontinued | 392MG 1.5G 15.2MG 23.9MG 567MG | New Report | 2019-08-12 | 91395 |
| DIANEAL PD 101 CAPD SOLUTION W 2.5% DEXTROSE | BAXTER CORPORATION | To be discontinued | 392MG 2.5G 15.2MG 23.9MG 567MG | New Report | 2019-08-12 | 91399 |
| NUTRINEAL PD4 | BAXTER CORPORATION | To be discontinued | 57MG 71.4MG 27MG 102MG 107.1MG 448MG 64.6MG 95.1MG 5.1MG 18.4MG 538MG 85MG 51MG 59.5MG 30MG 95.5MG 51MG 139.3MG 85MG | New Report | 2019-08-12 | 91385 |
